Similar articles for PMID: 30289755

Year	Number of Results
1945	2
1949	1
1952	1
1982	2
1989	1
1991	1
1994	1
1995	1
1996	2
1997	1
2000	3
2001	4
2002	2
2004	2
2005	1
2007	2
2008	2
2009	2
2010	4
2011	3
2012	3
2013	1
2014	4
2015	13
2016	8
2017	11
2018	20
2019	21
2020	11
2021	12
2022	7
2023	2

1

Genitourinary syndrome of menopause in breast cancer survivors:Treatments are available.

Moreno AC, Sikka SK, Thacker HL. Moreno AC, et al. Cleve Clin J Med. 2018 Oct;85(10):760-766. doi: 10.3949/ccjm.85a.17108. Cleve Clin J Med. 2018. PMID: 30289755 Free article. Review.

2

Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health.

Faubion SS, Larkin LC, Stuenkel CA, Bachmann GA, Chism LA, Kagan R, Kaunitz AM, Krychman ML, Parish SJ, Partridge AH, Pinkerton JV, Rowen TS, Shapiro M, Simon JA, Goldfarb SB, Kingsberg SA. Faubion SS, et al. Menopause. 2018 Jun;25(6):596-608. doi: 10.1097/GME.0000000000001121. Menopause. 2018. PMID: 29762200

3

Vaginal estrogen and mammogram results: case series and review of literature on treatment of genitourinary syndrome of menopause (GSM) in breast cancer survivors.

Zuo SW, Wu H, Shen W. Zuo SW, et al. Menopause. 2018 Jul;25(7):828-836. doi: 10.1097/GME.0000000000001079. Menopause. 2018. PMID: 29533365 Review.

4

Management of genitourinary syndrome of menopause in female cancer patients: a focus on vaginal hormonal therapy.

Crean-Tate KK, Faubion SS, Pederson HJ, Vencill JA, Batur P. Crean-Tate KK, et al. Am J Obstet Gynecol. 2020 Feb;222(2):103-113. doi: 10.1016/j.ajog.2019.08.043. Epub 2019 Aug 29. Am J Obstet Gynecol. 2020. PMID: 31473229 Review.

5

Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?

Trinkaus M, Chin S, Wolfman W, Simmons C, Clemons M. Trinkaus M, et al. Oncologist. 2008 Mar;13(3):222-31. doi: 10.1634/theoncologist.2007-0234. Oncologist. 2008. PMID: 18378532 Free article. Review.

6

The Impact of Vaginal Laser Treatment for Genitourinary Syndrome of Menopause in Breast Cancer Survivors: A Systematic Review and Meta-analysis.

Jha S, Wyld L, Krishnaswamy PH. Jha S, et al. Clin Breast Cancer. 2019 Aug;19(4):e556-e562. doi: 10.1016/j.clbc.2019.04.007. Epub 2019 Apr 19. Clin Breast Cancer. 2019. PMID: 31227415 Free article.

7

Managing Genitourinary Syndrome of Menopause in Breast Cancer Survivors Receiving Endocrine Therapy.

Sussman TA, Kruse ML, Thacker HL, Abraham J. Sussman TA, et al. J Oncol Pract. 2019 Jul;15(7):363-370. doi: 10.1200/JOP.18.00710. J Oncol Pract. 2019. PMID: 31291563 Review.

8

Local hormone therapy for genitourinary syndrome of menopause in breast cancer patients: is it safe?

Oyarzún MFG, Castelo-Branco C. Oyarzún MFG, et al. Gynecol Endocrinol. 2017 Jun;33(6):418-420. doi: 10.1080/09513590.2017.1290076. Epub 2017 Feb 21. Gynecol Endocrinol. 2017. PMID: 28277141 Review.

9

Genitourinary Syndrome Of Menopause and Vaginal Estrogen Use.

Steele NM, Ledbetter CA, Bernier F. Steele NM, et al. Urol Nurs. 2016 Mar-Apr;36(2):59-65, 71. Urol Nurs. 2016. PMID: 27281861 Review.

10

Breast Cancer and the Obstetrician-Gynecologist: A Focus on Screening, Risk Assessment and Treatment of Survivors With Genitourinary Syndrome of Menopause.

Jasra B, Samiian L, Kaunitz AM. Jasra B, et al. Clin Obstet Gynecol. 2019 Dec;62(4):634-643. doi: 10.1097/GRF.0000000000000479. Clin Obstet Gynecol. 2019. PMID: 31259841 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed